Two months later, however, the patient had radiographic progression, and treatment was discontinued [10]. Boyer et al. describe a case of a 53-year-old male with a high-grade glioneuronal tumor positive for STRN1-NTRK2 fusion. Here, NTRK2 is linked to mixed neuronal-glial tumor.